(Q38476382)

3 September 2017

1 reference

title

What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)? (English)

1 reference

3 September 2017

Stewart F

1

1 reference

3 September 2017

Baas P

series ordinal

2

1 reference

3 September 2017

Star W

series ordinal

3

1 reference

3 September 2017

publication date

1 September 1998

1 reference

Radiotherapy and Oncology

3 September 2017

published in

1 reference

3 September 2017

volume

48

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

233-248

1 reference

Hypoxic cell sensitisers in radiotherapy

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Fractionated treatment of CaD2 tumors in mice sensitized with aluminium phthlocyanine tetrasulfonate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Fluorescent markers of hypoxic cells: a comparison of two compounds on three cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Distribution and elimination of Photofrin II in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Effect of light fluence rate on mammalian cells photosensitization by chloroaluminium phthalocyanine tetrasulphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Integral photoradiation therapy of multifocal bladder tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy and the treatment of neoplastic diseases of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Distribution of hematoporphyrin derivative in the rat 9L gliosarcoma brain tumor analyzed by digital video fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Structure and biodistribution relationships of photodynamic sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy with systemic administration of photosensitizers in dermatology.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photosensitized oxidation of biomaterials and related model compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy (PDT) of malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Cutaneous phototoxic occurrences in patients receiving Photofrin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

RADIATION RESPONSE OF MAMMALIAN CELLS GROWN IN CULTURE. V. TEMPERATURE DEPENDENCE OF THE REPAIR OF X-RAY DAMAGE IN SURVIVING CELLS (AEROBIC AND HYPOXIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy using mTHPC for malignant disease in the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Clinical and preclinical photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Definition of type I and type II photosensitized oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Dosimetry in photodynamic therapy: oxygen and the critical importance of capillary density

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Oxygen consumption and diffusion effects in photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

How does photodynamic therapy work?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

A transient mathematical model of oxygen depletion during photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In vivo intravascular laser photodynamic therapy in rabbit atherosclerotic lesions using a lateral direction fiber

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Interstitial photodynamic therapy. Clinical experience with diffusing fibres in the treatment of cutaneous and subcutaneous tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In situ light dosimetry during whole bladder wall photodynamic therapy: clinical results and experimental verification

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In vitro photodynamic therapy of human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Effect of bleaching of porphyrin sensitizers during photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photoinduced degradation and modification of Photofrin II in cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Applicator for light delivery and in situ light dosimetry during endobronchial photodynamic therapy: First measurements in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy in the management of resistant lower urinary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Therapy of glioblastoma multiforme: a cumulative experience of 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy of esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Intrapleural photodynamic therapy: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

A theoretical study of light fractionation and dose-rate effects in photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Prostanoid antagonists inhibit the response of the microcirculation to "early" photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Mouse skin photosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy using SnET2 for basal cell nevus syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Human tissue levels and plasma pharmacokinetics of temoporfin (Foscan®, mTHPC)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Long-term survival after photodynamic therapy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Light dosimetry in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Light dosimetry for photodynamic therapy by whole bladder wall irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Electromotive diffusion (EMD) and photodynamic therapy with delta-aminolaevulinic acid (delta-ALA) for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Intracavitary photodynamic therapy for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic treatment of rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Performance of a light applicator for photodynamic therapy in the oral cavity: calculations and measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Changes in perfusion of mouse tumours after photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Does tumour uptake of Foscan determine PDT efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Foscan-mediated photodynamic therapy for a peritoneal-cancer model: drug distribution and efficacy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

The importance of fluence rate in photodynamic therapy: is there a parallel with ionizing radiation dose-rate effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Radiation reduces cyclooxygenase activity in cultured human endothelial cells at low doses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Quantitation of Hematoporphyrin Derivative in Human Gliomas, Experimental Central Nervous System Tumors, and Normal Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Distribution and excretion of radiolabeled temoporfin in a murine tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

Use of photodynamic therapy for the treatment of extensive basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900063-2

7 January 2021

10.1016/S0167-8140(98)00063-2

Identifiers

DOI

1 reference

3 September 2017

1 reference